Abstract B213: Toward better preclinical combination studies: Using constrained optimization techniques in combination dosage and study design

Abstract Dose-limiting toxicities limit the potential of many oncology agents, including targeted therapies. Combination therapies provide a path forward for widening the dose-response window, particularly if efficacy combines in an additive or synergistic manner, while toxicity is subadditive or no...

Full description

Saved in:
Bibliographic Details
Published inMolecular cancer therapeutics Vol. 12; no. 11_Supplement; p. B213
Main Authors Chen, Andrew, Collins, Sabrina, Mettetal, Jerome, Manfredi, Mark, Galvin, Katherine, Shyu, Wen Chyi, Ecsedy, Jeffrey, Palani, Santhosh, Chakravarty, Arijit
Format Journal Article
LanguageEnglish
Published 01.11.2013
Online AccessGet full text

Cover

Loading…